Biocon Limited BIOCON.NS
BIOCON.NS
Biocon Limited LAURUSLABS.NS
Laurus Labs Limited LAURUSLABS.BO
Laurus Labs Limited GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited GLENMARK.BO
Glenmark Pharmaceuticals Limited GLENMARK.NS
Glenmark Pharmaceuticals Limited SYNGENE.BO
Syngene International Limited SYNGENE.NS
Syngene International Limited ASTERDM.NS
Aster DM Healthcare Limited
Biocon Limited LAURUSLABS.NS
Laurus Labs Limited LAURUSLABS.BO
Laurus Labs Limited GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited GLENMARK.BO
Glenmark Pharmaceuticals Limited GLENMARK.NS
Glenmark Pharmaceuticals Limited SYNGENE.BO
Syngene International Limited SYNGENE.NS
Syngene International Limited ASTERDM.NS
Aster DM Healthcare Limited
Performance
| Periode | BIOCON.NS | LAURUSLABS.NS | LAURUSLABS.BO | GLAXO.BO | GLAXO.NS | GLENMARK.BO | GLENMARK.NS | SYNGENE.BO | SYNGENE.NS | ASTERDM.NS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 10.30 % | 44.28 % | 44.30 % | -1.91 % | -2.01 % | 35.55 % | 35.55 % | -11.46 % | -11.42 % | 43.70 % |
| YTD | -0.73 % | 50.07 % | 50.21 % | 23.62 % | 23.60 % | 14.97 % | 14.92 % | -26.93 % | -27.00 % | 38.83 % |
| 1Y | 8.51 % | 98.58 % | 98.76 % | 4.30 % | 4.35 % | 8.19 % | 8.07 % | -24.95 % | -24.94 % | 68.80 % |
| 3Y | 36.20 % | 90.01 % | 89.53 % | 103.84 % | 103.46 % | 366.08 % | 365.95 % | 10.89 % | 10.92 % | 194.84 % |
| 5Y | -16.72 % | 176.74 % | 176.85 % | 82.02 % | 82.04 % | 278.95 % | 279.04 % | 16.69 % | 16.24 % | 424.64 % |
| 10Y | 385.42 % | 861.59 % | 861.34 % | 67.60 % | 67.02 % | 81.98 % | 82.25 % | 241.93 % | 242.05 % | 298.21 % |
| From the beginning | 807.54 % | 861.59 % | 861.34 % | 599.95 % | 797.17 % | 8 869.07 % | 6 741.45 % | 313.53 % | 313.38 % | 298.21 % |